LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Implementing Regulation (EU) 2019/921 of 3 June 2019 concerning the classification of certain goods in the Combined Nomenclature

Commission Implementing Regulation (EU) 2019/921 of 3 June 2019 concerning the classification of certain goods in the Combined Nomenclature

Implementing Regulation (EU) 2019/921 · Regulation · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The goods described in column (1) of the table set out in the Annex shall be classified within the Combined Nomenclature under the CN code indicated in column (2) of that table.

Article 2

Open ↗

Binding tariff information which does not conform to this Regulation may continue to be invoked in accordance with Article 34(9) of Regulation (EU) No 952/2013 for a period of three months from the date of entry into force of this Regulation.

Article 3

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Description of the goods Classification (CN code) Reasons (1) (2) (3) A product in the form of a tablet, containing 400 mg of S-Adenosyl–L-Methionine disulfate p-toluenesulfonate, of which S-Adenosyl–L-Methionine (‘SAMe’) is the active ingredient. The product contains also minor quantities of microcrystalline cellulose, magnesium hydroxide, stearic acid, magnesium stearate, colloidal silica anhydrous, calcium oxide and coating components. The product is presented to be used as a food supplement that facilitates normal function of the liver, helps body detox processes and generally supports good emotional health. The recommended daily dosage is one tablet. The product is presented in bulk. 2106 90 92 Classification is determined by general rules 1 and 6 for the interpretation of the Combined Nomenclature, additional note 5 to Chapter 21 and the wording of CN codes 2106 , 2106 90 and 2106 90 92 . The content of the active ingredient, ‘SAMe’, per tablet is not suitable for the prevention and treatment of diseases or ailments. Classification under heading 3004 is therefore excluded. Consequently, the product is a food preparation not elsewhere specified or included (see also the Harmonized System Explanatory Notes to heading 2106 , second paragraph, point (16)). The product is therefore to be classified under CN code 2106 90 92 as a food preparation not elsewhere specified or included.

Other acts of the same type
Commission Implementing Regulation (EU) 2025/1876 of 16 September 2025 granting a Union authorisation for the single biocidal product Septihol IPA products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1878 of 16 September 2025 granting a Union authorisation for the biocidal product family BPF Propanol in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1879 of 16 September 2025 renewing the approval of the low-risk active substance rape seed oil in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011Commission Implementing Regulation (EU) 2025/1903 of 15 September 2025 on the approval of an amendment to the product specification of the protected designation of origin Vesuvio pursuant to Regulation (EU) 2024/1143 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1853 of 12 September 2025 amending Regulation (EU) No 468/2010 establishing the EU list of vessels engaged in illegal, unreported and unregulated fishingCommission Implementing Regulation (EU) 2025/1861 of 12 September 2025 correcting Commission Implementing Regulation (EU) 2021/1266 imposing a definitive anti-dumping duty on imports of biodiesel originating in the United States of America following an expiry review pursuant to Article 11(2) of Regulation (EU) 2016/1036 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1866 of 12 September 2025 correcting Implementing Regulation (EU) 2025/261 imposing a definitive anti-dumping duty on imports of biodiesel originating in the People’s Republic of ChinaCommission Implementing Regulation (EU) 2025/1868 of 12 September 2025 correcting Implementing Regulation (EU) 2025/835 imposing a definitive countervailing duty on imports of biodiesel originating in Argentina following an expiry review pursuant to Article 18 of Regulation (EU) 2016/1037 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1869 of 12 September 2025 correcting Implementing Regulation (EU) 2021/1267 imposing definitive countervailing duties on imports of biodiesel originating in the United States of America following an expiry review pursuant to Article 18 of Regulation (EU) 2016/1037 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1870 of 12 September 2025 correcting the Polish language version of Implementing Regulation (EU) 2024/2174 laying down rules for the application of Regulation (EU) 2024/573 of the European Parliament and of the Council as regards the format of the labels for certain products and equipment containing fluorinated greenhouse gasesCouncil Implementing Regulation (EU) 2025/1894 of 12 September 2025 implementing Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCommission Implementing Regulation (EU) 2025/1897 of 12 September 2025 amending for the 349th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da’esh) and Al-Qaida organisations

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next